Hui-Fang Liang (Huifang Liang, Liang Hui-Fang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Transcription Factor

Histone Deacetylase

Cell Proliferation

Top Venues

Cell death and differentiation

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yiming Luo, Zhi Li, He Zhu, Junli Lu, Zhen Lei, Chen Su, Furong Liu, Hongwei Zhang, Qibo Huang, Shenqi Han, Dean Rao, Tiantian Wang, Xiaoping Chen, Hong Cao, Zhiwei Zhang, Wenjie Huang, Hui-Fang Liang
Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2. MedComm 5 (5) (2024)
Lei Xu, Qiumeng Liu, Hailing Liu, Feimu Fan, Pengcheng Li, Shiwei Yue, Jie Mo, Zhicheng Liu, Renshun Dong, Xuewu Zhang, Hanhua Dong, Hui-Fang Liang, Xiao-Ping Chen, Bixiang Zhang, Lin Chen, Jin Chen
Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT. Cell death and differentiation (2024)
Yiming Luo, Zhi Li, He Zhu, Junli Lu, Zhen Lei, Chen Su, Furong Liu, Hongwei Zhang, Qibo Huang, Shenqi Han, Dean Rao, Tiantian Wang, Xiaoping Chen, Hong Cao, Zhiwei Zhang, Wenjie Huang, Hui-Fang Liang
Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2. MedComm 5 (5) (2024)
Yi He, Shenqi Han, Han Li, Yu Wu, Wenlong Jia, Zeyu Chen, Yonglong Pan, Ning Cai, Jingyuan Wen, Ganxun Li, Junnan Liang, Jianping Zhao, Qiumeng Liu, Hui-Fang Liang, Zeyang Ding, Bixiang Zhang, Bixiang Zhang
CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38. MedComm 5 (7) (2024)
Hailing Liu, Lei Xu, Shiwei Yue, Hongfei Su, Xing Chen, Qiumeng Liu, Hui Li, Hui-Fang Liang, Xiaoping Chen, Jiefeng He, Zeyang Ding, Bixiang Zhang
Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer communications (London, England) (2024)
Yi He, Shenqi Han, Han Li, Yu Wu, Wenlong Jia, Zeyu Chen, Yonglong Pan, Ning Cai, Jingyuan Wen, Ganxun Li, Junnan Liang, Jianping Zhao, Qiumeng Liu, Hui-Fang Liang, Zeyang Ding, Bixiang Zhang, Bixiang Zhang
CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38. MedComm 5 (7) (2024)
Jin Chen, Deng Ning, Pengcheng Du, Qiumeng Liu, Jie Mo, Hui-Fang Liang, Wanguang Zhang, Mingzhi Zhang, Li Jiang, Bixiang Zhang, Xiaoping Chen
USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma. Oncogene (2023)
Yi-Xiao Xiong, Xiao-Chao Zhang, Jing-Han Zhu, Yu-Xin Zhang, Yong-Long Pan, Yu Wu, Jian-Ping Zhao, Jun-Jie Liu, Yuan-Xiang Lu, Hui-Fang Liang, Zhan-Guo Zhang, Wan-Guang Zhang
Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. Cell death and differentiation (2023)
Wen-Ya Huang, Zhi-Bin Liao, Jia-Cheng Zhang, Xin Zhang, Hong-Wei Zhang, Hui-Fang Liang, Zun-Yi Zhang, Tao Yang, Jia Yu, Ke-Shuai Dong
USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling. Cell death & disease 13 (11) (2022)
Xiaochao Zhang, Yabing Hu, Yonglong Pan, Yixiao Xiong, Yuxin Zhang, Mengzhen Han, Keshuai Dong, Jia Song, Hui-Fang Liang, Zeyang Ding, Xuewu Zhang, He Zhu, Qiumeng Liu, Xun Lu, Yongdong Feng, Xiaoping Chen, Zhan-Guo Zhang, Bixiang Zhang
DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6. Oncogene 41 (12) (2022)
Chen Jin, Dong Han-Hua, Liu Qiu-Meng, Ning Deng, Du Peng-Chen, Mo Jie, Xu Lei, Zhang Xue-Wu, Hui-Fang Liang, Chen Yan, Xiaoping Chen, Bixiang Zhang
MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma. Oncogene (2022)
Hongwei Zhang, Zhibin Liao, Weijian Wang, Yachong Liu, He Zhu, Hui-Fang Liang, Bixiang Zhang, Xiao-Ping Chen
A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis. Oncogene (2022)
Junnan Liang, Ganxun Li, Jingyu Liao, Zhao Huang, Jingyuan Wen, Yu Wang, Zeyu Chen, Guangzhen Cai, Weiqi Xu, Zeyang Ding, Hui-Fang Liang, Pran K Datta, Liang Chu, Xiao-Ping Chen, Bixiang Zhang
Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation. Cell death and differentiation 29 (5) (2022)
He Zhu, Hongwei Zhang, Youliang Pei, Zhibin Liao, Furong Liu, Chen Su, Yachong Liu, Renshun Dong, Jia Song, Xuewu Zhang, Yawei Fan, Hui-Fang Liang, Bixiang Zhang, Xiaoping Chen
Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Chengpeng Yu, Dean Rao, He Zhu, Qiumeng Liu, Wenjie Huang, Long Zhang, Hui-Fang Liang, Jia Song, Zeyang Ding
TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27. BioMed research international 2021 (2021)
Lu Zhang, Yachong Liu, Haisu Tao, He Zhu, Yonglong Pan, Pengcheng Li, Hui-Fang Liang, Bixiang Zhang, Jia Song
Circular RNA circUBE2J2 acts as the sponge of microRNA-370-5P to suppress hepatocellular carcinoma progression. Cell death & disease 12 (11) (2021)
Jinghan Zhu, Yixiao Xiong, Yuxin Zhang, Jingyuan Wen, Ning Cai, Kun Cheng, Hui-Fang Liang, Wan-Guang Zhang
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors. Oxidative medicine and cellular longevity 2020 (2020)